Actively Recruiting
TELESCOPE- TELEhealth Shared Decision-making COaching
Led by Rutgers, The State University of New Jersey · Updated on 2025-12-09
594
Participants Needed
2
Research Sites
206 weeks
Total Duration
On this page
Sponsors
R
Rutgers, The State University of New Jersey
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).
CONDITIONS
Official Title
TELESCOPE- TELEhealth Shared Decision-making COaching
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be between 50 and 77 years old
- Be a current or former smoker who quit within the past 15 years
- Have at least a 20 pack-year smoking history
- Be scheduled for a non-acute care visit at a study site
- Primary care clinicians, clinic directors, nursing directors, clinic practice administrators, or study navigators aged 18 or older and fluent in English may participate in interviews or surveys
You will not qualify if you...
- Do not speak English
- Have a history of lung cancer
- Were screened for lung cancer within the past 12 months
- Have health conditions making curative treatment unlikely as determined by a primary care provider
- Are unable to provide informed consent
- Women who are pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Rutgers Cancer Institute
New Brunswick, New Jersey, United States, 08901
Actively Recruiting
2
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Active, Not Recruiting
Research Team
J
Julie E Chapman-Greene, PhD, MPH
CONTACT
R
Rebecca Ayala
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here